Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Henry Schein Animal Health to merge with Vets First Choice
Henry Schein and Vets First Choice expect the new business to grow such that in year three, operating income synergies will be in excess of $100 million.
Spin off to bring new global animal health company 

Henry Schein is set to spin off its animal health business and merge with Vets First Choice, launching a new public company.

The new company, called Vets First Corp., will be headquartered in Portland, Maine. It is promising to ‘provide veterinarians with a powerful new platform to grow their practices, improve client engagement, and drive better health outcomes for pets’.

Upon completion of the transaction, Henry Schein shareholders will own approximately 63 per cent of the new company, while Vets First Choice shareholders will own 37 per cent. Henry Schein is expected to receive $1-1.25 billion in cash on a tax-free basis.

Ben Shaw, founder and CEO of Vets First Choice, who will become CEO of the new company, said: "This merger creates an enhanced value chain that connects the veterinarian, the manufacturer, and the pet owner through insights and analytics that will support better clinical and financial outcomes.

“This new global animal health care company is focused on improving clinical compliance by facilitating the delivery of care how, when, and where the pet owner wants it."

Henry Schein and Vets First Choice expect the new business to grow such that in year three, operating income synergies will be in excess of $100 million.

The transaction is expected to close by the end of 2018. 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'